跳至主要内容
临床试验/IRCT20200313046756N2
IRCT20200313046756N2尚未招募3 期

a pilot study to Assess the therapeutics indicators in Patients With Acute Myeloid Leukemia Undergoing therapy With deferasirox in Afzalipour Hospital of Kerman

Kerman University of Medical Sciences0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
尚未招募
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65 years(—)
性别
All

入选标准

  • Age between 18-65 years
  • AML/non-AP

排除标准

  • HIV infected patients or Hepatitis B,C patients
  • Patients with AML-induced neurological involvement
  • Patients with uncontrolled blood pressure and heart failure
  • Patients with a history of ocular toxicity due to iron chelators drugs

研究者

相似试验